Daclatasvir plus simeprevir with or without ribavirin for the treatment of chronic hepatitis C virus genotype 1 infection

Authors:

Abstract
No abstract available
Funding Information
  • Bristol-Myers Squibb

This publication has 15 references indexed in Scilit: